09 Mar Uncategorized EastGate Biotech Enters into a Financial Agreement March 9, 2022 By admin 0 comments EastGate Biotech Enters into a Financial Agreement Terms of the Agreement reflects long term vision and supports company’s busin...Continue reading
09 Mar Uncategorized EastGate Biotech Announces Joint Venture with Netris/Origin Biopharmaceuticals for Pakistani Market March 9, 2022 By admin 0 comments Drug Development and Nutraceuticals Covered in JV. WEST CALDWELL, NJ and TORONTO, April 17, 2018 (AccessNewswire-) Eas...Continue reading
09 Mar Uncategorized EastGate Biotech Announces Definitive Agreement with Genluiching Mining Corporation. March 9, 2022 By admin 0 comments EastGate to receive funding in tranches up to $5 million USD. WEST CALDWELL, NJ and TORONTO, April 10, 2018 (AccessNewswire-) ...Continue reading
09 Mar Uncategorized EastGate Biotech Corp., CEO Anna Gluskin and President, Rose Perri Visit Uptick Newswire’s “Stock Day” with Everett Jolly March 9, 2022 By admin 0 comments https://finance.yahoo.com/news/eastgate-biotech-corp-ceo-anna-120000005.htmlContinue reading
09 Mar Uncategorized EastGate Biotech Announces that it has reached a Definitive Settlement Agreement with Northbridge Financial Inc.. March 9, 2022 By admin 0 comments The Share Reserve with Transfer Agent has been cancelled and all remaining shares have been returned to EastGate Biotech. WEST C...Continue reading
09 Mar Uncategorized EASTGATE BIOTECH ENTERS INTO A MOU WITH GENLUICHING MINING CORP. & AAH & INTERNATIONAL ASSOCIATES INC. OF THE PHILIPPINES March 9, 2022 By admin 0 comments WEST CALDWELL, NJ and TORONTO, March 13, 2018 (AccessNewswire-) EastGate Biotech Corp. (PinkSheets: ETBI), a pharmaceutical company...Continue reading
09 Mar Uncategorized EASTGATE BIOTECH ANNOUNCES LICENSING/DISTRIBUTION MOU WITH BUPHARCO FOR THE INSULIN MOUTH RINSE IN THE PHILIPPINES FOR TYPE 2 DIABETES PATIENTS March 9, 2022 By admin 0 comments WEST CALDWELL, NJ and TORONTO, March 5, 2018 (AccessNewswire-) EastGate Biotech Corp. (PinkSheets: ETBI), a pharmaceutical company that...Continue reading
09 Mar Uncategorized EASTGATE BIOTECH ANNOUNCES LICENSING/DISTRIBUTION MOU WITH BUPHARCO FOR THE INSULIN MOUTH RINSE IN THE PHILIPPINES FOR TYPE 2 DIABETES PATIENTS March 9, 2022 By admin 0 comments WEST CALDWELL, NJ and TORONTO, March 5, 2018 (AccessNewswire-) EastGate Biotech Corp. (PinkSheets: ETBI), a pharmaceutical company ...Continue reading
09 Mar Uncategorized EASTGATE BIOTECH PROVIDES CORPORATE UPDATE March 9, 2022 By admin 0 comments WEST CALDWELL, NJ and TORONTO, February 27, 2018 (AccessNewswire/-) EastGate Biotech Corp. (PinkSheets: ETBI), an emerging pharmaceutic...Continue reading
09 Mar Uncategorized EastGate Biotech Announces Annual Report Form 10-K Filing March 9, 2022 By admin 0 comments Toronto, ON, February 28th, 2018 – EastGate Biotech (OTC BB: ETBI) a market leading pharmaceutical technology company, today announce...Continue reading